Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This forecasted FDA funding opportunity targets outsourcing facilities and aims to reduce fraud and lower barriers to producing drugs currently in shortage. It is likely relevant mainly to pharmace…
- Deadline
- Not specified
- Posted
- Jul 21, 2025
- Award amount
- Amount not specified
In plain English
This forecasted FDA funding opportunity targets outsourcing facilities and aims to reduce fraud and lower barriers to producing drugs currently in shortage. It is likely relevant mainly to pharmaceutical manufacturers/outsourcing facilities rather than typical small nonprofits; eligibility, funding amount, and deadline are not yet published.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration · Up to $250K · Due Jan 29, 2027
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration · Up to $200K · Due Apr 1, 2027
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration · Up to $300K · Due Apr 1, 2027
Laboratory Flexible Funding Model (LFFM)
Food and Drug Administration · Up to $1.5M · Due Jan 11, 2028
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Up to $600K · Due Feb 8, 2028
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration · Up to $900K · Due May 16, 2028
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.